Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project #sort descending RFA # PI/Project Leader Institution Title Status
2016 R33 RFA-CA-15-005 JOHANN, DONALD UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT AND VALIDATION OF A MICRODISSECTION METHOD TO ADVANCE PRECISION MEDICINE IN THE CLINICAL SETTING Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2016 R33 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2016 R33 RFA-CA-15-003 SIMS, PETER ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES LARGE-SCALE INTEGRATION OF SINGLE CELL RNA-SEQ AND HIGH-CONTENT IMAGING FOR ANALYZING DRUG RESPONSE IN CANCER Complete
2016 R21 RFA-CA-15-002 LIANG, FU-SEN UNIVERSITY OF NEW MEXICO NOVEL BI-FUNCTIONAL INHIBITORS BLOCKING ONCOMIR BIOGENESIS Complete
2016 R21 RFA-CA-15-004 GARCIA, ANDRES J GEORGIA INSTITUTE OF TECHNOLOGY USHEAR TECHNOLOGY FOR CANCER CELL PURIFICAITON Complete
2016 R21 RFA-CA-15-002 HELD, JASON M. WASHINGTON UNIVERSITY DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER Complete
2016 R33 RFA-CA-15-003 NAGRATH, SUNITHA UNIVERSITY OF MICHIGAN HIGH THROUGHPUT GO CHIP ISOLATION OF LUNG CTCS FOR MOLECULAR DIAGNOSIS AND DRUG TESTING Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2016 R21 RFA-CA-15-002 RECHT, MICHAEL PALO ALTO RESEARCH CENTER HIGH-THROUGHPUT SCREENING PLATFORM FOR CANCER DRUG DISCOVERY Complete
2016 R21 RFA-CA-15-004 SULCHEK, TODD GEORGIA INSTITUTE OF TECHNOLOGY LABEL-FREE MICROFLUIDIC ENRICHMENT OF CANCER CELLS FROM NONCANCER CELLS IN ASCITES FLUID Complete
2016 R33 RFA-CA-15-003 QUEIMADO, MARIA DE LURDES UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR A NOVEL MOLECULAR ASSAY FOR EARLY DETECTION AND ASSESSMENT OF CANCER RISK Complete
2016 R33 RFA-CA-15-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER A GENETIC TOOLBOX FOR THE IDENTIFICATION AND INTERROGATION OF TUMOR CELLS OF ORIGIN, PROPAGATION, AND RECURRENCE FROM PATIENT-DERIVED ONCOGENIC DRIVERS Complete
2016 R43 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2016 R43 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2016 R33 RFA-CA-15-005 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA VALIDATION OF A ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete
2016 R33 RFA-CA-15-003 SCARCELLI, GIULIANO UNIV OF MARYLAND, COLLEGE PARK BRILLOUIN CONFOCAL MICROSCOPY FOR BIOMECHANICAL STUDIES OF METASTATIC CASCADE IN 3D MICROENVIRONMENTS Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2016 R21 RFA-CA-15-004 JAHNKE, FRANK SONATA BIOSCIENCES, INC. A NEW SAMPLE PREPARATION METHOD TO DELVE DEEPER INTO THE PROTEOME Complete
2016 R21 RFA-CA-15-004 VANDER GRIEND, DONALD JAMES UNIVERSITY OF CHICAGO SUPRAMOLECULAR MATRIX MATERIALS FOR PROSTATE CANCER CELL BIOLOGY Complete
2016 R21 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA Complete
2016 R21 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2016 R33 RFA-CA-15-003 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH-THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R33 RFA-CA-15-003 SCHULTZ, ZACHARY UNIVERSITY OF NOTRE DAME ONLINE RAMAN DIAGNOSTICS OF ONCOMETABOLITES Complete
2016 R33 RFA-CA-15-003 SPICER, TIMOTHY PATRICK SCRIPPS FLORIDA ADVANCED DEVELOPMENT AND VALIDATION OF 3 DIMENSIONAL SPHEROID CULTURE OF PRIMARY CANCER CELLS USING NANO3D TECHNOLOGY Complete
2016 R21 RFA-CA-15-002 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE TRANSFORMING FLUORESCENCE LIFETIME IMAGING MICROSCOPY INTO A FAST AND SIMPLE PLATFORM FOR HIGH-CONTENT MOLECULAR ANALYSIS Complete
2016 R33 RFA-CA-15-003 BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN TRANSLATIONAL MOLECULAR AND CELLULAR IMAGING TECHNOLOGIES FOR PROSTATE TUMOR PATHOLOGY Complete
2021 R21 CA20-017 HOSHIKA, SHUICHI FOUNDATION FOR APPLIED MOLECULAR EVOLUTN High Quality Proteins with Multiple Post Translational Modifications Active
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Complete
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Complete
2020 R21 RFA-CA-19-019 HATTORI, TAKAMITSU NEW YORK UNIVERSITY SCHOOL OF MEDICINE Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications Complete
2020 R33 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2020 R21 RFA-CA-19-019 LI, WEI TEXAS TECH UNIVERSITY Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip Active
2020 R21 RFA-CA-19-021 GUPTA, GAUTAM UNIVERSITY OF LOUISVILLE Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens Active
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2020 R21 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Complete
2020 R43 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma Complete
2016 R33 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2016 R33 RFA-CA-15-003 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY Protein painting identifies therapeutic targets at protein-protein interfaces Complete
2016 R33 RFA-CA-15-003 WEISS, GREGORY A. UNIVERSITY OF CALIFORNIA-IRVINE Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications Complete

Pages